L-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
暂无分享,去创建一个
S. Hazen | Zeneng Wang | B. Levison | Yuping Wu | M. Copeland | Xiaoming Fu | J. DiDonato | W. Tang | J. C. Garcia-Garcia | Xiaodong Gu | D. Cody | Lin Li | H. Dai | Robert A. Koeth | Xinmin S Li | M. Culley | David Bartlett | Betzabe Rachel Lam-Galvez | Jennifer Kirsop | Xinmin S. Li | W. Tang | H. J. Dai | S. L. Hazen | Betzabe Rachel Lam-Galvez | Matthew F. Copeland | David B. Cody | Jose Carlos Garcia-Garcia | W. H. W. Tang
[1] M. Fischbach,et al. Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential , 2018, Circulation research.
[2] Jennifer M. Brown,et al. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N‐oxide‐generating pathway, modulates platelet responsiveness and thrombosis risk , 2018, Journal of thrombosis and haemostasis : JTH.
[3] S. Hazen,et al. Development of a gut microbe-targeted non-lethal therapeutic to inhibit thrombosis potential , 2018, Nature Medicine.
[4] Yue Han,et al. Circulating trimethylamine N‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies , 2017, Journal of cellular and molecular medicine.
[5] A. Sannino,et al. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis , 2017, European heart journal.
[6] J. Manson,et al. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies , 2017, Journal of the American Heart Association.
[7] D. Pieper,et al. Uncovering the trimethylamine-producing bacteria of the human gut microbiota , 2017, Microbiome.
[8] S. Hazen,et al. Gut Microbe-Generated Trimethylamine N-Oxide From Dietary Choline Is Prothrombotic in Subjects. , 2017, Circulation.
[9] L. Räber,et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors , 2017, European heart journal.
[10] F. Bäckhed,et al. Role of gut microbiota in atherosclerosis , 2017, Nature Reviews Cardiology.
[11] N. Powe,et al. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. , 2017, Journal of the American Society of Nephrology : JASN.
[12] A. Varki,et al. Human risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acid. , 2016, Molecular aspects of medicine.
[13] S. Hazen,et al. Intestinal Microbiota‐Generated Metabolite Trimethylamine‐N‐Oxide and 5‐Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE‐Like Patient Cohort , 2016, Journal of the American Heart Association.
[14] D. Raoult,et al. “Emergencia timonensis,” a new bacterium isolated from the stool of a healthy patient , 2016, New microbes and new infections.
[15] S. Hazen,et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk , 2016, Cell.
[16] Donald J L Jones,et al. Trimethylamine N-oxide and prognosis in acute heart failure , 2016, Heart.
[17] S. Hazen,et al. Choline Diet and Its Gut Microbe–Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload–Induced Heart Failure , 2016, Circulation. Heart failure.
[18] S. Hazen,et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis , 2015, Cell.
[19] M. Urashima,et al. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study , 2015, Clinical and Experimental Nephrology.
[20] F. Hu,et al. Red and processed meat consumption and mortality: dose–response meta-analysis of prospective cohort studies , 2015, Public Health Nutrition.
[21] T. Karlsen,et al. Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure , 2015, Journal of internal medicine.
[22] Ji Miao,et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis , 2015, Nature Communications.
[23] F. Rey,et al. Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide , 2015, mBio.
[24] S. Hazen,et al. Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease , 2015, Circulation research.
[25] C. J. McAdam,et al. Comparison of inverse and regular 2-pyridyl-1,2,3-triazole "click" complexes: structures, stability, electrochemical, and photophysical properties. , 2015, Inorganic chemistry.
[26] J. Ravel,et al. Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks , 2015, Gut.
[27] S. Hazen,et al. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. , 2015, Annual review of medicine.
[28] Brian J. Bennett,et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis[S] , 2015, Journal of Lipid Research.
[29] Brian J. Bennett,et al. Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation* , 2014, The Journal of Biological Chemistry.
[30] S. Hazen,et al. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. , 2014, Cell metabolism.
[31] M. Blaser. The microbiome revolution. , 2014, The Journal of clinical investigation.
[32] T. Norat,et al. Association between total, processed, red and white meat consumption and all-cause, CVD and IHD mortality: a meta-analysis of cohort studies. , 2014, The British journal of nutrition.
[33] K. Rajakumar,et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota , 2014, Proceedings of the National Academy of Sciences.
[34] N. Güzel,et al. THE EFFECTS OF ACUTE L-CARNITINE SUPPLEMENTATION ON ENDURANCE PERFORMANCE OF ATHLETES. , 2014 .
[35] S. Hazen,et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.
[36] F. Bushman,et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.
[37] Brian J. Bennett,et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. , 2013, Cell metabolism.
[38] An Pan,et al. Red meat consumption and mortality: results from 2 prospective cohort studies. , 2012, Archives of internal medicine.
[39] T. Librowski,et al. L-carnitine--metabolic functions and meaning in humans life. , 2011, Current drug metabolism.
[40] J. Clemente,et al. Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans , 2011, Science.
[41] Fumio Nomura,et al. Use of the MALDI BioTyper system with MALDI–TOF mass spectrometry for rapid identification of microorganisms , 2011, Analytical and bioanalytical chemistry.
[42] Brian J. Bennett,et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.
[43] I. Macdonald,et al. Chronic oral ingestion of l‐carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans , 2011, The Journal of physiology.
[44] D. Raoult,et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] L. Fricker,et al. Multiple isotopic labels for quantitative mass spectrometry. , 2008, Analytical chemistry.
[46] Frédéric Mazué,et al. Changes in l-carnitine content of fish and meat during domestic cooking. , 2008, Meat science.
[47] E. Topol,et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis , 2007, Nature Medicine.
[48] C. Rebouche. Kinetics, Pharmacokinetics, and Regulation of l‐Carnitine and Acetyl‐l‐carnitine Metabolism , 2004, Annals of the New York Academy of Sciences.
[49] M. Soty,et al. Radioisotopic determination of l-carnitine content in foods commonly eaten in Western countries , 2004 .
[50] Don C Des Jarlais,et al. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. , 2004, American journal of public health.
[51] E. Strack,et al. Verwertung von Trimethylammoniumverbindungen durch Acinetobacter calcoaceticus , 1977, Archives of Microbiology.
[52] C. Rebouche,et al. Carnitine metabolism and its regulation in microorganisms and mammals. , 1998, Annual review of nutrition.
[53] H. Kleber,et al. Bacterial carnitine metabolism. , 1997, FEMS microbiology letters.
[54] M. Vukovich,et al. Carnitine supplementation: effect on muscle carnitine and glycogen content during exercise. , 1994, Medicine and science in sports and exercise.
[55] K. J. Cole,et al. Effect of L-carnitine supplementation on muscle and blood carnitine content and lactate accumulation during high-intensity sprint cycling. , 1994, International journal of sport nutrition.
[56] M. Vukovich,et al. The Effects of L-Carnitine Supplementation on Performance During Interval Swimming , 1994, International journal of sports medicine.
[57] E. Jéquier,et al. Effect of L-carnitine on submaximal exercise metabolism after depletion of muscle glycogen. , 1993, Medicine and science in sports and exercise.
[58] C. Rebouche. Quantitative estimation of absorption and degradation of a carnitine supplement by human adults. , 1991, Metabolism: clinical and experimental.
[59] C. Rebouche,et al. Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites. , 1991, The Journal of nutrition.
[60] S. Turnbull,et al. Preparation of crystalline sodium norcarnitine: an easily handled precursor for the preparation of carnitine analogs and radiolabeled carnitine. , 1987, Analytical biochemistry.
[61] L. Brady,et al. Active-site probes of carnitine acyltransferases. Inhibition of carnitine acetyltransferase by hemiacetylcarnitinium, a reaction intermediate analogue. , 1986, Biochemical and biophysical research communications.
[62] J. Bremer. Carnitine--metabolism and functions. , 1983, Physiological reviews.
[63] C. Rebouche,et al. Significance of renal gamma-butyrobetaine hydroxylase for carnitine biosynthesis in man. , 1980, The Journal of biological chemistry.
[64] H. Seim,et al. [Utilization of trimethylammonium-compounds by Acinetobacter calcoaceticus (author's transl)]. , 1977, Archives of microbiology.
[65] N. Benoiton,et al. A new method of quaternizing amines and its use in amino acid and peptide chemistry , 1976 .
[66] G. Lindstedt. Hydroxylation of γ-Butyrobetaine to Carnitine in Rat Liver* , 1967 .